5-溴-2-氟苯硼酸 | 112204-57-6

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯硼酸系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-溴-2-氟苯硼酸
• 中文别名: 5-溴-2-氟苯基硼酸
• 英文名称: (5-bromo-2-fluorophenyl)boronic acid
• 英文别名: dihydroxy-(5-bromo-2-fluorophenyl)-borane；5-Bromo-2-fluorophenylboronic acid
• CAS: 112204-57-6
• 化学式: C₆H₅BBrFO₂
• 分子量: 218.818
• InChiKey: IGBDPRKNAFOOGY-UHFFFAOYSA-N

物化性质

• 熔点：
  144-149 °C (lit.)
• 沸点：
  324.8±52.0 °C(Predicted)
• 密度：
  1.75±0.1 g/cm3(Predicted)
• 稳定性/保质期：
  如果遵照规格使用和储存，则不会分解，未有已知危险反应。请避免与强氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.27
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT, KEEP COLD
• 危险品标志：
  Xi
• WGK Germany：
  3
• 海关编码：
  2931900090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
5-Bromo-2-fluorophenylboronic acid
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
5-Bromo-2-fluorophenylboronic acid
Ingredient name:
CAS number: 112204-57-6

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H5BBrFO2
Molecular weight: 218.8

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-2-氟苯硼酸 在 sodium hydroxide 、 正丁基锂 、 双氧水 、 溴 作用下， 以 四氢呋喃 、 乙醚 、 氯仿 、 水 为溶剂， 反应 0.5h， 生成 2-溴-4-氟-5-甲氧基苯甲醛
  参考文献：
  名称：

  取代的二卤代苯与丁基锂之间的卤素-锂交换：在官能化溴代苯甲醛的区域选择性合成中的应用

  摘要：

  非对称取代的单官能和双官能二卤代苯C 6 H 3 XHal 2和C 6 H 2 XYHal 2之间的卤素-锂互变反应（Hal = Br，I； X，Y = F，OR，CF 3，CH（OMe）2）研究了丁基锂和丁基锂。将所得的有机锂中间体以中等至良好的产率转化成相应的苯甲醛。通常，邻位的溴原子官能团中的α优先被锂取代。具有双功能系统的分子内竞争实验表明，与甲氧基和二甲氧基甲基相比，氟能够更强地激活相邻的溴原子。用碘代替未活化的溴后，由于优选的碘-锂交换，可以完全逆转这种反应模式。

  DOI：

  10.1016/j.tet.2005.04.051
• 作为产物：
  描述：

  (5-bromo-2-fluorophenyl)-dimethoxyborane 在 溶剂黄146 作用下， 以 四氢呋喃 、 hexanes 为溶剂， 反应 0.5h， 生成 5-溴-2-氟苯硼酸
  参考文献：
  名称：

  WO2006/76246

  摘要：

  公开号：
• 作为试剂：
  描述：

  2,4-二溴-1-氟苯 、 镁 、 硼酸三甲酯 、 溶剂黄146 在 氮气 、 水 、 乙醚 、 四氯化碳 、 5-溴-2-氟苯硼酸 作用下， 以 四氢呋喃 、 乙醚 、 水 为溶剂， 反应 1.67h， 生成 5-溴-2-氟苯硼酸
  参考文献：
  名称：

  Intermediates useful in the production of pesticides

  摘要：

  一种制备III式硼酸的方法，##STR1##其中式IV的有机金属化合物，##STR2##其中式IV，M代表金属基团，例如--MgX，X代表卤素或碱金属，与式B（OR）.sub.3的三烷氧基硼烷反应，其中R代表烷基，然后水解产物。

  公开号：

  US05283371A1

文献信息

• [EN] IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS<br/>[FR] DERIVES D'IMIDAZO-PYRIDINE UTILISES EN TANT QUE LIGANDS POUR LES RECEPTEURS GABA
  申请人：MERCK SHARP & DOHME

  公开号：WO2003099816A1

  公开（公告）日：2003-12-04

  A class of 8-fluoro-3-phenylimidazo[1,2-a]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group, or by a pyrrolidinonyl group, which is directly attached or bridged by an oxygen atom or by a -NH- or -OCH2- linkage, being selective ligands for GABAA receptors, in particular having high affinity for the α2 and/or α3 and/or α5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类8-氟-3-苯基咪唑并[1,2-a]吡啶衍生物，通过苯环的间位被一个可选择取代的芳基或杂环芳基团，或者通过一个吡咯烷基团取代，该吡咯烷基团直接连接或通过氧原子或-NH-或-OCH2-键连接，作为GABAA受体的选择性配体，特别是对其α2和/或α3和/或α5亚基具有高亲和力，因此在治疗和/或预防中枢神经系统的不良状况，包括焦虑、惊厥和认知障碍方面具有益处。
• 3,5-(Un)substituted-1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H- pyrrolo[2,3-b]pyrazine dual ITK and JAK3 Kinase Inhibitors
  申请人：Arrien Pharmaceuticals LLC

  公开号：US20140315909A1

  公开（公告）日：2014-10-23

  The present invention relates to compounds described by Formula I: salts thereof, their synthesis, and their use as ITK and JAK3 inhibitors including such compounds and methods of using said compounds in the treatment of various diseases and or disorders such disease associated with abnormal cell growth such as autoimmune, inflammation, rheumatoid arthritis, systemic lupus erythematosus, atherosclerosis, ulcerative colitis, psoriatic arthritis, psoriasis, Crohn's, metabolic and cancer diseases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions and processes for preparing the compounds of the invention.

  本发明涉及由式I描述的化合物： 其盐，它们的合成，以及它们作为ITK和JAK3抑制剂的用途，包括这些化合物以及使用这些化合物治疗各种疾病和/或疾病的方法，这些疾病与异常细胞生长有关，如自身免疫、炎症、类风湿关节炎、系统性红斑狼疮、动脉粥样硬化、溃疡性结肠炎、银屑病性关节炎、银屑病、克罗恩病、代谢和癌症疾病。本发明还提供包括本发明化合物的药学上可接受的组合物以及使用这些组合物的方法和制备本发明化合物的方法。
• [EN] MIDAZOPYRAZINONES AND IMIDAZOTRIAZINONES DERIVATES AS GABA-A RECEPTOR ANXIOLYTIC<br/>[FR] DERIVES DE MIDAZOPYRAZINONES ET D'IMIDAZOTRIAZINONES UTILISES COMME ANXIOLYTIQUES AGISSANT VIA LE RECEPTEUR GABA-A
  申请人：MERCK SHARP & DOHME

  公开号：WO2004041826A1

  公开（公告）日：2004-05-21

  The present invention discloses a compound of formula I, or a pharmaceutically acceptable salt thereof: (I) wherein -U-V- represents -CH=CH-, or -CH2-CH2-, -N=CH- or -CH=N-; X1 represents hydrogen, halogen, C1-6 alkyl, trifluoromethyl or C1-6 alkoxy; X2 represents hydrogen or halogen; Y represents a chemical bond, an oxygen atom, or a -NH- or -OCH2- linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrocarbon, a heterocyclic group, trifluoromethyl, -SO2Ra, -SO2NRaRb, -CORa, -CO2Ra or -CONRaRb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group;pharmaceutical compositions comprising it; its use in methods of treatment; use of it in the manufacture of a medicament for treating and/or preventing anxiety; convulsions or a cognitive disorder; and methods of treatment using it.

  本发明公开了公式I的化合物，或其药用可接受盐：(I) 其中，-U-V-代表-CH=CH-，或-CH2-CH2-，-N=CH-或-CH=N-；X1代表氢，卤素，C1-6烷基，三氟甲基或C1-6烷氧基；X2代表氢或卤素；Y代表化学键，氧原子，或-NH-或-OCH2-连接；Z代表可选地取代的芳香族或杂芳族基团；R1代表烃，杂环族，三氟甲基，-SO2Ra，-SO2NRaRb，-CORa，-CO2Ra或-CONRaRb；Ra和Rb独立代表氢，烃或杂环族；包含它的药物组合物；它用于治疗方法中的用途；用于治疗和/或预防焦虑；抽搐或认知障碍的药物制造中的用途；以及使用它的治疗方法。
• Palladium-Catalyzed Site-Selective Benzocylization of Aromatic Acids with <i>o</i>-Fluoro-Substituted Diaryliodonium Salts toward 3,4-Benzocoumarins
  作者：Cheng Pan、Limin Wang、Jianwei Han

  DOI：10.1021/acs.orglett.0c01577

  日期：2020.6.19

  By using 2-fluoro-substituted diaryliodonium salts, a novel benzocylization has been accomplished for the synthesis of 3,4-benzocoumarin derivatives via a cascade of ortho-arylation and defluorination in the presence of palladium catalysts. The reaction exhibits a broad compatibility of readily available aromatic acids with an excellent level of site-selectivity. Mechanistic investigations revealed

  通过用2-氟取代的二芳基碘盐，一种新颖的benzocylization已经完成用于经由级联的3,4-苯并香豆素衍生物合成邻-arylation和脱氟中的钯催化剂的存在下进行。该反应表现出容易获得的芳族酸的广泛相容性以及极好的位点选择性。机理研究表明，在本系统中，通过芳族氟化物的亲核取代，羧酸定向芳基化具有独特的反应性。
• ALKYNYL ALCOHOLS AND METHODS OF USE
  申请人：Genentech, Inc.

  公开号：US20150057260A1

  公开（公告）日：2015-02-26

  The invention relates to compounds of Formula (0): wherein A 1 -A 8 , R 4 and R 5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

  该发明涉及具有以下结构的化合物（0）：其中A1-A8，R4和R5分别具有如本文所述的含义。 公式（0）的化合物及其药物组成物在治疗观察到NF-kB信号不受欢迎或过度激活的疾病和紊乱中是有用的。